REVIEW
Published on 20 Nov 2023
Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
doi 10.3389/fendo.2023.1187870
- 1,735 views
- 3 citations
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Radionuclide Theranostics for the Management of Endocrine Cancers
Radionuclide Theranostics for the Management of Endocrine Cancers
8,730
Total downloads
25k
Total views and downloads
Articles
REVIEW
Published on 31 Oct 2022
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
doi 10.3389/fendo.2022.941832
- 15,189 views
- 36 citations
MINI REVIEW
Published on 12 Jul 2022
Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
doi 10.3389/fendo.2022.924841
- 3,601 views
- 10 citations
![[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center](https://www.frontiersin.org/files/myhome article library/778322/778322_Thumb_400.jpg)
ORIGINAL RESEARCH
Published on 07 Feb 2022
[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center
doi 10.3389/fendo.2022.778322
- 3,130 views
- 16 citations
Published in
Frontiers in Endocrinology
Cancer Endocrinology
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore